Telangiectatic osteosarcoma
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
D-2-HYDROXYGLUTARIC ACIDURIA 2
|
disease |
|
Disease or Syndrome
|
2
|
2
|
0.610 |
None |
1.000 |
5 |
2
|
2010 |
2018 |
Anaplastic Astrocytoma, IDH-Mutant
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Diffuse Astrocytoma, IDH-Wildtype
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Diffuse leptomeningeal glioneuronal neoplasm
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Rosette-forming glioneuronal neoplasm
|
disease |
|
Neoplastic Process
|
3
|
2
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hemangiomatosis
|
disease |
Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
3
|
1
|
0.100 |
None |
|
0 |
|
|
|
D-2-HYDROXYGLUTARIC ACIDURIA 1
|
disease |
|
Disease or Syndrome
|
4
|
15
|
0.320 |
None |
1.000 |
2 |
2
|
2010 |
2011 |
Mononeuritis Multiplex
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
D-2-hydroxyglutaric aciduria
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
5
|
6
|
0.040 |
None |
1.000 |
4 |
2
|
2010 |
2013 |
Diffuse infiltrative lymphocytosis syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Anaplastic Astrocytoma, IDH-Wildtype
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
14
|
0.450 |
None |
1.000 |
6 |
2
|
2010 |
2016 |
GLIOMA SUSCEPTIBILITY 1
|
phenotype |
|
Finding
|
6
|
14
|
0.300 |
None |
1.000 |
2 |
2
|
2009 |
2015 |
Hemangioma, Intramuscular
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Chondrogenic Neoplasm
|
disease |
Neoplasms; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chromosome 1, monosomy 1p
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anaplastic Oligoastrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
4
|
0.310 |
None |
1.000 |
6 |
1
|
2009 |
2014 |
Oligodendroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Mixed Oligodendroglioma-Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Childhood Anaplastic Oligoastrocytoma
|
disease |
|
Neoplastic Process
|
7
|
4
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Maffucci Syndrome
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
8
|
|
0.650 |
None |
1.000 |
5 |
|
2011 |
2016 |
Diffuse Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
9
|
7
|
0.100 |
None |
1.000 |
11 |
1
|
2014 |
2020 |
Squamous cell carcinoma of nasopharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |